Genetic variability of the ABCC2 gene and overall survival in pancreatic cancer
Author | Affiliation | |
---|---|---|
Gentiluomo, Manuel | ||
Date |
---|
2018-06-13 |
Objectives Context: The critical role of the ATP binding cassette subfamily C member 2 (ABCC2) protein in the response to various drugs has been documented in several reports. It is more recent knowledge that the ABCC2 gene is differently expressed in gemcitabine sensitive and resistant cells. Moreover, Single Nucleotide Polymorphisms (SNPs) in the gene have been associated with differential outcomes and prognosis in several tumour types. Objective: The aim of this study was to investigate the possible association between SNPs in the ABCC2 gene and overall survival in PDAC patients. Methods A total of 12 polymorphisms, including tagging-SNPs covering all the genetic variability of the ABCC2 gene, enriched by eQTL SNPs, were selected and genotyped in 3167 PDAC patients collected in the context the PANcreatic Disease ReseArch (PANDoRA) consortium. The association between ABCC2 SNPs and PDAC overall survival (OS) have been tested using Cox proportional hazard models. Results Considering all the patients together we did not observe any statistically significant association, however stratifying by stage we observed that two SNPs, rs3740067 and rs3740073, showed an association with worse OS (HR=2.19, 95% CI 1.38-6.17, p = 0.0052, and HR=2.75, 95% CI 1.34-5.62, p = 0.0057 respectively) in stage I patients. These two SNPs are strong modulators of gene expression in the pancreatic tissue according to the GTEx portal. Conclusion Our results suggest